Operating Expenses - Devyser Diagnostics AB (STO:DVYSR) - Alpha Spread
D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 117.5 SEK 0.43% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Operating Expenses Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Operating Expenses
-kr201m
CAGR 3-Years
-53%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Operating Expenses
-kr508.9m
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Operating Expenses
-kr609.8m
CAGR 3-Years
-31%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Operating Expenses
-kr5.6B
CAGR 3-Years
-137%
CAGR 5-Years
-68%
CAGR 10-Years
-38%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Operating Expenses
-kr13.9B
CAGR 3-Years
-24%
CAGR 5-Years
-23%
CAGR 10-Years
-23%
BioArctic AB
STO:BIOA B
Operating Expenses
-kr300.5m
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Operating Expenses?
Operating Expenses
-201m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Operating Expenses amounts to -201m SEK.

What is Devyser Diagnostics AB's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-43%

Over the last year, the Operating Expenses growth was -27%. The average annual Operating Expenses growth rates for Devyser Diagnostics AB have been -53% over the past three years , -43% over the past five years .

Back to Top